These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 7608251
1. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. Takeda T, Suzuki S, Liu RT, DeGroot LJ. J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251 [Abstract] [Full Text] [Related]
2. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone. Sakurai A, Miyamoto T, Refetoff S, DeGroot LJ. Mol Endocrinol; 1990 Dec; 4(12):1988-94. PubMed ID: 2082193 [Abstract] [Full Text] [Related]
3. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Zavacki AM, Harney JW, Brent GA, Larsen PR. Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663 [Abstract] [Full Text] [Related]
4. The function of retinoid X receptors on negative thyroid hormone response elements. Takeda T, Nagasawa T, Miyamoto T, Hashizume K, DeGroot LJ. Mol Cell Endocrinol; 1997 Apr 04; 128(1-2):85-96. PubMed ID: 9140079 [Abstract] [Full Text] [Related]
5. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao EH, Usala SJ, Bercu BB. Mol Endocrinol; 1992 Feb 04; 6(2):248-58. PubMed ID: 1569968 [Abstract] [Full Text] [Related]
6. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency. Meier CA, Parkison C, Chen A, Ashizawa K, Meier-Heusler SC, Muchmore P, Cheng SY, Weintraub BD. J Clin Invest; 1993 Oct 04; 92(4):1986-93. PubMed ID: 8408652 [Abstract] [Full Text] [Related]
7. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function. Piedrafita FJ, Ortiz MA, Pfahl M. Mol Endocrinol; 1995 Nov 04; 9(11):1533-48. PubMed ID: 8584031 [Abstract] [Full Text] [Related]
8. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer. Zhu XG, Yu CL, McPhie P, Wong R, Cheng SY. Endocrinology; 1996 Feb 04; 137(2):712-21. PubMed ID: 8593822 [Abstract] [Full Text] [Related]
9. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation. Nomura Y, Nagaya T, Tsukaguchi H, Takamatsu J, Seo H. Endocrinology; 1996 Oct 04; 137(10):4082-6. PubMed ID: 8828460 [Abstract] [Full Text] [Related]
10. L-thyroxine directly affects expression of thyroid hormone-sensitive genes: regulatory effect of RXRbeta. Bogazzi F, Bartalena L, Brogioni S, Burelli A, Grasso L, Dell'Unto E, Manetti L, Martino E. Mol Cell Endocrinol; 1997 Oct 31; 134(1):23-31. PubMed ID: 9406846 [Abstract] [Full Text] [Related]
11. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone. Ng L, Forrest D, Haugen BR, Wood WM, Curran T. Mol Endocrinol; 1995 Sep 31; 9(9):1202-13. PubMed ID: 7491112 [Abstract] [Full Text] [Related]
12. Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbA beta 1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone. Behr M, Ramsden DB, Loos U. J Clin Endocrinol Metab; 1997 Apr 31; 82(4):1081-7. PubMed ID: 9100577 [Abstract] [Full Text] [Related]
13. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors. Wong R, Zhu XG, Pineda MA, Cheng SY, Weintraub BD. Mol Med; 1995 Mar 31; 1(3):306-19. PubMed ID: 8529109 [Abstract] [Full Text] [Related]
14. Evidence that phosphorylation events participate in thyroid hormone action. Jones KE, Brubaker JH, Chin WW. Endocrinology; 1994 Feb 31; 134(2):543-8. PubMed ID: 8299553 [Abstract] [Full Text] [Related]
15. In vitro effect of Triac on resistance to thyroid hormone receptor mutants: potential basis for therapy. Messier N, Laflamme L, Hamann G, Langlois MF. Mol Cell Endocrinol; 2001 Mar 28; 174(1-2):59-69. PubMed ID: 11306172 [Abstract] [Full Text] [Related]
16. Structural features of thyroid hormone response elements that increase susceptibility to inhibition by an RTH mutant thyroid hormone receptor. Zavacki AM, Harney JW, Brent GA, Larsen PR. Endocrinology; 1996 Jul 28; 137(7):2833-41. PubMed ID: 8770904 [Abstract] [Full Text] [Related]
17. Retinoid-X receptor (RXR) differentially augments thyroid hormone response in cell lines as a function of the response element and endogenous RXR content. Hsu JH, Zavacki AM, Harney JW, Brent GA. Endocrinology; 1995 Feb 28; 136(2):421-30. PubMed ID: 7835272 [Abstract] [Full Text] [Related]
18. Triac regulation of transcription is T(3) receptor isoform- and response element-specific. Messier N, Langlois MF. Mol Cell Endocrinol; 2000 Jul 25; 165(1-2):57-66. PubMed ID: 10940484 [Abstract] [Full Text] [Related]
19. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1. Takeda T, Nagasawa T, Miyamoto T, Minemura K, Hashizume K, Degroot LJ. Thyroid; 2000 Jan 25; 10(1):11-8. PubMed ID: 10691308 [Abstract] [Full Text] [Related]
20. Functional properties of a mutant T3 receptor beta (R338W) identified in a subject with pituitary resistance to thyroid hormone. Sasaki S, Nakamura H, Tagami T, Miyoshi Y, Nakao K. Mol Cell Endocrinol; 1995 Aug 30; 113(1):109-17. PubMed ID: 8674808 [Abstract] [Full Text] [Related] Page: [Next] [New Search]